A comparison of a 5% potassium hydroxide solution with a 5‐fluorouracil and salicylic acid combination in the treatment of patients with anogenital warts: a randomized, open‐label clinical trial. (11th July 2014)
- Record Type:
- Journal Article
- Title:
- A comparison of a 5% potassium hydroxide solution with a 5‐fluorouracil and salicylic acid combination in the treatment of patients with anogenital warts: a randomized, open‐label clinical trial. (11th July 2014)
- Main Title:
- A comparison of a 5% potassium hydroxide solution with a 5‐fluorouracil and salicylic acid combination in the treatment of patients with anogenital warts: a randomized, open‐label clinical trial
- Authors:
- Işik, Selda
Koca, Rafet
Sarici, Gülben
Altinyazar, Hilmi Cevdet - Abstract:
- <abstract abstract-type="main" id="ijd12505-abs-0001"> <title>Abstract</title> <p>Anogenital warts are caused by human papillomavirus (HPV), over 30 types of which are infectious for the anogenital tract. Without treatment, warts may regress spontaneously, remain unchanged, or increase in number and size. This study compared the efficacy of a topical 5% potassium hydroxide (KOH) solution with that of a topical 0.5% 5‐fluorouracil (5‐FU) and 10% salicylic acid (SA) combination in the treatment of anogenital warts. Sixty patients were randomly assigned to receive topical KOH or 5‐FU + SA. Both groups demonstrated a significant decrease in numbers of lesions (<italic>P </italic>&lt;<italic> </italic>0.05), but this difference was not significant at week 12 (<italic>P </italic>&gt; 0.05). The mean number of lesions decreased from baseline to week 12 from 17.03 ± 12.64 to 3.73 ± 7.30 and from 16.13 ± 12.97 to 3.10 ± 4.90 in the KOH and 5‐FU + SA groups, respectively (<italic>P </italic>&lt; 0.001). Excellent clearance was achieved by 70.0 and 76.7% of patients in the KOH and 5‐FU + SA groups, respectively. Marked improvement was seen in 13.3 and 20.0% of patients in the KOH and 5‐FU + SA groups, respectively. At week 16, relapse was observed in two patients in the KOH group and three in the 5‐FU + SA group (<italic>P </italic>&gt; 0.05). No serious adverse events were reported. Neither treatment was more efficacious. Safety and ease of application are important goals in<abstract abstract-type="main" id="ijd12505-abs-0001"> <title>Abstract</title> <p>Anogenital warts are caused by human papillomavirus (HPV), over 30 types of which are infectious for the anogenital tract. Without treatment, warts may regress spontaneously, remain unchanged, or increase in number and size. This study compared the efficacy of a topical 5% potassium hydroxide (KOH) solution with that of a topical 0.5% 5‐fluorouracil (5‐FU) and 10% salicylic acid (SA) combination in the treatment of anogenital warts. Sixty patients were randomly assigned to receive topical KOH or 5‐FU + SA. Both groups demonstrated a significant decrease in numbers of lesions (<italic>P </italic>&lt;<italic> </italic>0.05), but this difference was not significant at week 12 (<italic>P </italic>&gt; 0.05). The mean number of lesions decreased from baseline to week 12 from 17.03 ± 12.64 to 3.73 ± 7.30 and from 16.13 ± 12.97 to 3.10 ± 4.90 in the KOH and 5‐FU + SA groups, respectively (<italic>P </italic>&lt; 0.001). Excellent clearance was achieved by 70.0 and 76.7% of patients in the KOH and 5‐FU + SA groups, respectively. Marked improvement was seen in 13.3 and 20.0% of patients in the KOH and 5‐FU + SA groups, respectively. At week 16, relapse was observed in two patients in the KOH group and three in the 5‐FU + SA group (<italic>P </italic>&gt; 0.05). No serious adverse events were reported. Neither treatment was more efficacious. Safety and ease of application are important goals in treatments for anogenital warts. A 5% KOH solution is a promising alternative treatment because it is effective and inexpensive and causes minimal side effects.</p> </abstract> … (more)
- Is Part Of:
- International journal of dermatology. Volume 53:Number 9(2014:Sep.)
- Journal:
- International journal of dermatology
- Issue:
- Volume 53:Number 9(2014:Sep.)
- Issue Display:
- Volume 53, Issue 9 (2014)
- Year:
- 2014
- Volume:
- 53
- Issue:
- 9
- Issue Sort Value:
- 2014-0053-0009-0000
- Page Start:
- 1145
- Page End:
- 1150
- Publication Date:
- 2014-07-11
- Subjects:
- Dermatology -- Periodicals
616.5 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=ijd ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/ijd.12505 ↗
- Languages:
- English
- ISSNs:
- 0011-9059
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.185000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3615.xml